PIN1 and acute promyelocytic leukemia: Although there are many identified Pin1-targeted inhibitors, which exert anticancer activity in in vitro experiments, in animal models and even in some APL patients, many Pin1 inhibitors share poor aqueous solubility which limits their clinical applications.